Of America Corp /De/ Bank Acquires 670 Shares of HCA Healthcare, Inc. (NYSE:HCA) Stock

HCA Healthcare, Inc. (NYSE:HCAGet Free Report) major shareholder Of America Corp /De/ Bank acquired 670 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, July 26th. The shares were purchased at an average cost of $27.97 per share, with a total value of $18,739.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $342.25 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The firm has a market capitalization of $84.26 billion, a P/E ratio of 15.58, a PEG ratio of 1.10 and a beta of 1.68. The firm has a fifty day moving average of $324.53 and a 200-day moving average of $341.25. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the business earned $5.90 earnings per share. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a $0.72 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.84%. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Analyst Ratings Changes

Several equities research analysts recently commented on HCA shares. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. Morgan Stanley decreased their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Barclays reduced their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. KeyCorp reduced their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Finally, Royal Bank of Canada cut their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $385.67.

View Our Latest Analysis on HCA

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of HCA. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at approximately $31,000. Tidemark LLC bought a new position in HCA Healthcare during the 4th quarter valued at $36,000. Legacy Investment Solutions LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter worth about $39,000. Activest Wealth Management lifted its position in shares of HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares during the last quarter. Finally, Pinnacle Bancorp Inc. raised its stake in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

About HCA Healthcare

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.